Prestige Wealth Management Group LLC Alnylam Pharmaceuticals, Inc. Transaction History
Prestige Wealth Management Group LLC
- $443 Million
- Q1 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 472 shares of ALNY stock, worth $118,486. This represents 0.02% of its overall portfolio holdings.
Number of Shares
472
Previous 278
69.78%
Holding current value
$118,486
Previous $53,000
32.08%
% of portfolio
0.02%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ALNY
# of Institutions
585Shares Held
104MCall Options Held
2.82MPut Options Held
1.75M-
Capital World Investors Los Angeles, CA12.8MShares$3.21 Billion0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$3.01 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.03MShares$2.27 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA7.21MShares$1.81 Billion0.2% of portfolio
-
Baillie Gifford & CO6.62MShares$1.66 Billion0.78% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...